{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7222,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a stepped process diagram to illustrate dose escalation cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/13",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-13",
      "loopMatches": [
        {
          "to": 19,
          "from": 6,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
          "evidence": "The solution section presents a clear 'why' for Spyre's approach",
          "position": 1,
          "objective": "Why does Spyre's approach make sense?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 6,
          "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "traction",
      "function": "analyze_data",
      "notes": "The slide uses a comparative bar chart approach to justify the human half-life prediction based on NHP data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/14",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-14",
      "loopMatches": [
        {
          "to": 19,
          "from": 6,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
          "evidence": "The solution section presents a clear 'why' for Spyre's approach",
          "position": 1,
          "objective": "Why does Spyre's approach make sense?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 6,
          "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "Uses icon-based visualization to represent injection frequency.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/15",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-15",
      "loopMatches": [
        {
          "to": 19,
          "from": 6,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
          "evidence": "The solution section presents a clear 'why' for Spyre's approach",
          "position": 1,
          "objective": "Why does Spyre's approach make sense?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 6,
          "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide uses a combination of a pharmacokinetic simulation line chart and a bar chart showing clinical remission rates by exposure quartile.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/16",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-16",
      "loopMatches": [
        {
          "to": 19,
          "from": 6,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
          "evidence": "The solution section presents a clear 'why' for Spyre's approach",
          "position": 1,
          "objective": "Why does Spyre's approach make sense?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 6,
          "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a timeline-like visual to compare dosing schedules at weeks 0, 2, and 6.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/17",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-17",
      "loopMatches": [
        {
          "to": 19,
          "from": 6,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
          "evidence": "The solution section presents a clear 'why' for Spyre's approach",
          "position": 1,
          "objective": "Why does Spyre's approach make sense?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 6,
          "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a comparative table for safety metrics and a bar chart for ADA rates to establish clinical equivalence/safety.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/18",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-18",
      "loopMatches": [
        {
          "to": 19,
          "from": 6,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
          "evidence": "The solution section presents a clear 'why' for Spyre's approach",
          "position": 1,
          "objective": "Why does Spyre's approach make sense?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 6,
          "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/19",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-19",
      "loopMatches": [
        {
          "to": 19,
          "from": 6,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
          "evidence": "The solution section presents a clear 'why' for Spyre's approach",
          "position": 1,
          "objective": "Why does Spyre's approach make sense?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 6,
          "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/20",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/21",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The funnel diagram illustrates the selection criteria: Monomer/Trimer binder -> Picomolar potency -> Extended half-life.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/22",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses two distinct chart types to demonstrate potency (dose-response curve) and diversity (scatter plot of IC50 vs Relative DcR3/DR3 Blocking).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/23",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/24",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 24,
          "beatId": "0d553f9e-bdc3-4321-9290-0329c7071225",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Competition",
          "beatSlug": "sequoia-pitch-competition",
          "evidence": "The document presents a competitive analysis on page 24",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/25",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/26",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/27",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological process diagram to illustrate the mechanism of action for three distinct therapeutic assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/28",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a stacked bar chart to visualize the additive clinical remission rates, noting a 22% delta between the individual components and the combination.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/29",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/30",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/31",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/32",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide includes a section for Management team and Board of Directors with headshots and titles, plus a logo grid at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/33",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 33,
          "from": 33,
          "beatId": "36d78305-5dbf-4639-888e-af1ef6ade8b1",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "The document presents a team section on page 33",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "traction",
      "function": "plan_implementation",
      "notes": "The slide uses a timeline-like structure to map clinical catalysts against expected timeframes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/34",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/35",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "other",
      "function": "summarize",
      "notes": "The slide details a corporate M&A event and subsequent private placement financing.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/36",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
      "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Spyre Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a footnote regarding a 1-for-25 reverse stock split effective September 8, 2023.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/37",
      "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
      "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The logo features negative space silhouettes of a person and a dog within the letters.",
      "imagePath": "https://imgproxy.kitesheet.com/RNRuXy8vfQWeTdj6-QxrjvUddku48NxtHzWKuEioRDI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ4MGU2N2EwODNjYmRlNTYzNjk0ZDI0ZmQ5Y2RjOC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/1",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 2,
          "from": 1,
          "beatId": "a251dbee-4536-4069-9442-726ec0659c7c",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Is",
          "beatSlug": "sparkline-what-is-1",
          "evidence": "The cover slides introduce the theme.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/glPpRii3ZubzjFiZpG8ge5U6pRqengHwwrnflb5S89Y/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ4MGU2N2EwODNjYmRlNTYzNjk0ZDI0ZmQ5Y2RjOC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/IDriIlqzdxu3xeAzYAtnVhD-Js8v9M152i1da9KRYZg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ4MGU2N2EwODNjYmRlNTYzNjk0ZDI0ZmQ5Y2RjOC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/ddUDPDw6sTj511iMQ0rTGc4HsOkZTRv2EMmh78jtW0k/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ4MGU2N2EwODNjYmRlNTYzNjk0ZDI0ZmQ5Y2RjOC9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The visual uses a silhouette of a man with a dog's shadow, reinforcing the premise.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/2",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 2,
          "from": 1,
          "beatId": "a251dbee-4536-4069-9442-726ec0659c7c",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Is",
          "beatSlug": "sparkline-what-is-1",
          "evidence": "The cover slides introduce the theme.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "ceo_quote",
      "function": "establish_context",
      "notes": "The slide features a personal narrative and a photo of the director on set.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/3",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-3",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "12015b19-bbe1-4e9c-a55f-80ebeebf48d4",
          "evidence": "The director's statement and synopsis provide insight into the project's 'why'.",
          "position": 0,
          "objective": "Understand the project's purpose and values.",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "bb06295e-2355-467c-8334-4c0bec5b918a",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Ordinary World",
          "beatSlug": "heros-journey-ordinary-world",
          "evidence": "The director's statement and synopsis provide context.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "other",
      "function": "other",
      "notes": "The slide uses a movie still (likely from 'Clueless') to illustrate the narrative.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/4",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-4",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "12015b19-bbe1-4e9c-a55f-80ebeebf48d4",
          "evidence": "The director's statement and synopsis provide insight into the project's 'why'.",
          "position": 0,
          "objective": "Understand the project's purpose and values.",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "bb06295e-2355-467c-8334-4c0bec5b918a",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Ordinary World",
          "beatSlug": "heros-journey-ordinary-world",
          "evidence": "The director's statement and synopsis provide context.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "other",
      "function": "illustrate_case",
      "notes": "The slide uses a split-image layout to define the film's visual world-building.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/5",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-5",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "12015b19-bbe1-4e9c-a55f-80ebeebf48d4",
          "evidence": "The director's statement and synopsis provide insight into the project's 'why'.",
          "position": 0,
          "objective": "Understand the project's purpose and values.",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "bb06295e-2355-467c-8334-4c0bec5b918a",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Ordinary World",
          "beatSlug": "heros-journey-ordinary-world",
          "evidence": "The director's statement and synopsis provide context.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}